Herpesviruses: Basic, Applicative, and Translational Studies

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Virology".

Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 21451

Special Issue Editor


E-Mail Website
Guest Editor
School of Medicine, Fujita Health University, Toyoake, Japan
Interests: Epstein-Barr virus; gene function analysis; epigenetics; transcription; cancer; infection mode; lytic infection; reactivation; latent infection; EB virus
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Herpesvirus is an enveloped virus with an icosahedral capsid and a large, double stranded DNA genome encoding hundreds of genes. There are 9 species of human herpesviruses: HSV-1, HSV-2, VZV, HCMV, HHV-6A, HHV-6B, HHV-7, EBV, and KSHV. Other animals also have their own unique herpesviruses, such as porcine PRV, bovine BHV, and simian herpes B.

This Special Issue aims to highlight basic, applicative, and translational studies on herpesviruses. Basic research is important for dissecting the molecular mechanisms of herpesvirus replication. Recent advancements in omics and gene editing technologies used in conjunction with classical recombinant virus technology represent a powerful tool for the basic analysis of herpesviruses. Herpesviruses cause a variety of disorders, and efficient antivirals and prophylaxes are still awaited. Therefore, translational study is also quintessential to cope with these complicated disorders. In addition, some of herpesviruses have been used as vectors for gene delivery and oncolytic therapy.

For this Special Issue, original research articles, review articles as well as short communications are welcome. Research areas may include (but not limited to) the following: viral replication, viral gene expression, latency and reactivation, glycoprotein, tegument protein, viral enzyme, omics analysis, host factor, evasion from immunity, antiviral drug, vaccine, animal model, gene therapy, and oncolytic therapy.

You may choose our Joint Special Issue in Microbiology Research.

I look forward to receiving your contributions.

Prof. Dr. Takayuki Murata
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review

9 pages, 1205 KiB  
Article
Effect of Lactococcus lactis Strain Plasma on HHV-6 and HHV-7 Shedding in Saliva: A Prospective Observational Study
by Hiroki Miura, Masaru Ihira, Kei Kozawa, Yoshiki Kawamura, Yuki Higashimoto, Fumihiko Hattori and Tetsushi Yoshikawa
Microorganisms 2021, 9(8), 1683; https://doi.org/10.3390/microorganisms9081683 - 8 Aug 2021
Cited by 1 | Viewed by 2723
Abstract
HHV-6 and HHV-7 can reactivate in the salivary gland in response to various host stresses. Lactococcus lactis strain Plasma (LC-Plasma) can activate plasmacytoid dendritic cells (pDCs) and decrease viral infection. We investigated whether LC-Plasma intake could decrease HHV-6 and HHV-7 reactivation in the [...] Read more.
HHV-6 and HHV-7 can reactivate in the salivary gland in response to various host stresses. Lactococcus lactis strain Plasma (LC-Plasma) can activate plasmacytoid dendritic cells (pDCs) and decrease viral infection. We investigated whether LC-Plasma intake could decrease HHV-6 and HHV-7 reactivation in the salivary gland. A total of 54 healthy volunteers were enrolled in this study. Participants took LC-Plasma granules daily for 6 weeks. Saliva samples were collected from subjects weekly for 4 weeks before (first), during (second), and after (third period) LC-Plasma intake. There was a 2-week interval between the first and second periods and a 3-week interval between the second and third periods. Mean salivary HHV-6 and HHV-7 DNA loads were compared among the three observation periods. In the first period (baseline data of viral DNA shedding), HHV-6 DNA shedding was significantly higher in subjects under 40 years old, and HHV-7 DNA shedding was significantly higher in males. HHV-6 and HHV-7 DNA loads did not significantly differ between periods. Meanwhile, in a subgroup analysis of the subjects under 40 years old, HHV-6 DNA load was significantly lower in the second period than in the first period. LC-Plasma decreases HHV-6 reactivation in the salivary glands in younger adults. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Figure 1

16 pages, 2849 KiB  
Article
Kaposi’s Sarcoma-Associated Herpesvirus ORF7 Is Essential for Virus Production
by Yuki Iwaisako, Tadashi Watanabe, Mizuki Hanajiri, Yuichi Sekine and Masahiro Fujimuro
Microorganisms 2021, 9(6), 1169; https://doi.org/10.3390/microorganisms9061169 - 28 May 2021
Cited by 5 | Viewed by 3065
Abstract
Kaposi’s sarcoma-associated herpesvirus (KSHV) causes Kaposi’s sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman disease. Although capsid formation and maturation in the alpha-herpesvirus herpes simplex virus 1 are well understood, these processes in KSHV remain unknown. The KSHV ORF7, encoding the viral terminase [...] Read more.
Kaposi’s sarcoma-associated herpesvirus (KSHV) causes Kaposi’s sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman disease. Although capsid formation and maturation in the alpha-herpesvirus herpes simplex virus 1 are well understood, these processes in KSHV remain unknown. The KSHV ORF7, encoding the viral terminase (DNA cleavage and packaging protein), is thought to contribute to capsid formation; however, functional information is lacking. Here, we investigated the role of ORF7 during KSHV lytic replication by generating two types of ORF7 knock-out (KO) mutants (frameshift-induced and stop codon-induced ORF7 deficiency), KSHV BAC16, and its revertants. The results revealed that both ORF7-KO KSHVs showed significantly reduced viral production but there was no effect on lytic gene expression and viral genome replication. Complementation assays showed virus production from cells harboring ORF7-KO KSHV could be recovered by ORF7 overexpression. Additionally, exogenously expressed ORF7 partially induced nuclear relocalization of the other terminase components, ORF29 and ORF67.5. ORF7 interacted with both ORF29 and ORF67.5, whereas ORF29 and ORF67.5 failed to interact with each other, suggesting that ORF7 functions as a hub molecule in the KSHV terminase complex for interactions between ORF29 and ORF67.5. These findings indicate that ORF7 plays a key role in viral replication, as a component of terminase. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Graphical abstract

19 pages, 13136 KiB  
Article
Live-Cell Analysis of Human Cytomegalovirus DNA Polymerase Holoenzyme Assembly by Resonance Energy Transfer Methods
by Veronica Di Antonio, Giorgio Palù and Gualtiero Alvisi
Microorganisms 2021, 9(5), 928; https://doi.org/10.3390/microorganisms9050928 - 26 Apr 2021
Cited by 4 | Viewed by 3074
Abstract
Human cytomegalovirus (HCMV) genome replication is a complex and still not completely understood process mediated by the highly coordinated interaction of host and viral products. Among the latter, six different proteins form the viral replication complex: a single-stranded DNA binding protein, a trimeric [...] Read more.
Human cytomegalovirus (HCMV) genome replication is a complex and still not completely understood process mediated by the highly coordinated interaction of host and viral products. Among the latter, six different proteins form the viral replication complex: a single-stranded DNA binding protein, a trimeric primase/helicase complex and a two subunit DNA polymerase holoenzyme, which in turn contains a catalytic subunit, pUL54, and a dimeric processivity factor ppUL44. Being absolutely required for viral replication and representing potential therapeutic targets, both the ppUL44–pUL54 interaction and ppUL44 homodimerization have been largely characterized from structural, functional and biochemical points of view. We applied fluorescence and bioluminescence resonance energy transfer (FRET and BRET) assays to investigate such processes in living cells. Both interactions occur with similar affinities and can take place both in the nucleus and in the cytoplasm. Importantly, single amino acid substitutions in different ppUL44 domains selectively affect its dimerization or ability to interact with pUL54. Intriguingly, substitutions preventing DNA binding of ppUL44 influence the BRETmax of protein–protein interactions, implying that binding to dsDNA induces conformational changes both in the ppUL44 homodimer and in the DNA polymerase holoenzyme. We also compared transiently and stably ppUL44-expressing cells in BRET inhibition assays. Transient expression of the BRET donor allowed inhibition of both ppUL44 dimerization and formation of the DNA polymerase holoenzyme, upon overexpression of FLAG-tagged ppUL44 as a competitor. Our approach could be useful both to monitor the dynamics of assembly of the HCMV DNA polymerase holoenzyme and for antiviral drug discovery. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Figure 1

10 pages, 1253 KiB  
Article
Hippocampal Atrophy in Pediatric Transplant Recipients with Human Herpesvirus 6B
by Misa Miyake, Yoshiki Kawamura, Naoko Ishihara, Shigetaka Suzuki, Hiroki Miura, Yoko Sakaguchi, Masaharu Tanaka, Yoshiyuki Takahashi, Seiji Kojima, Hiroshi Toyama, Jun Natsume and Tetsushi Yoshikawa
Microorganisms 2021, 9(4), 776; https://doi.org/10.3390/microorganisms9040776 - 8 Apr 2021
Viewed by 2143
Abstract
The aim of this study was to determine whether human herpesvirus 6B (HHV-6B) infection can impair the hippocampus in pediatric hematopoietic stem cell transplant (HSCT) recipients. Study subjects were pediatric HSCT recipients monitored for HHV-6B infection who underwent brain MRI before and after [...] Read more.
The aim of this study was to determine whether human herpesvirus 6B (HHV-6B) infection can impair the hippocampus in pediatric hematopoietic stem cell transplant (HSCT) recipients. Study subjects were pediatric HSCT recipients monitored for HHV-6B infection who underwent brain MRI before and after transplantation. Volumetric analysis of the hippocampus was performed. Of the 107 patients that received HSCT at Nagoya University Hospital Between July 2008 and April 2014, 20 were eligible for volumetric analysis. Eight patients had HHV-6B infection, of whom two had encephalopathy at the time of HHV-6B infection. None of the 12 patients without HHV-6B infection had encephalopathy. The median ratio of the right hippocampal volume from before to after transplantation was 0.93 in patients with HHV-6B infection and 1.02 in without HHV-6B infection (p = 0.007). The median ratio of the left hippocampal volume ratio in patients with and without HHV-6B infection was 0.92 and 1.00, respectively (p = 0.003). Among the eight patients with HHV-6B infection, four had a marked reduction in hippocampal volume (volume ratio < 0.90). Only one of these patients had neurological symptoms at the time of HHV-6B infection. The reduction in the hippocampal volume ratio was higher in pediatric HSCT recipients with HHV-6B infection than those without viral infection. Neurological follow-up may be required for pediatric HSCT recipients with HHV-6B infection. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Figure 1

Review

Jump to: Research

13 pages, 2849 KiB  
Review
Functionalized Noble Metal Nanoparticles for the Treatment of Herpesvirus Infection
by Martyna Janicka, Katarzyna Ranoszek-Soliwoda, Grzegorz Chodaczek, Małgorzata Antos-Bielska, Marek Brytan, Emilia Tomaszewska, Grzegorz Celichowski, Jarosław Grobelny, Joanna Cymerys, Małgorzata Krzyżowska and Marcin Chodkowski
Microorganisms 2022, 10(11), 2161; https://doi.org/10.3390/microorganisms10112161 - 31 Oct 2022
Cited by 2 | Viewed by 1515
Abstract
Neuroinfections caused by herpesviruses, mainly by HHV-1, represent a significant problem for modern medicine due to the small number of therapeutic substances available in the pharmaceutical sector. Furthermore, HHV-1 infection has been linked to neurodegenerative processes such as Alzheimer’s disease, which justifies the [...] Read more.
Neuroinfections caused by herpesviruses, mainly by HHV-1, represent a significant problem for modern medicine due to the small number of therapeutic substances available in the pharmaceutical sector. Furthermore, HHV-1 infection has been linked to neurodegenerative processes such as Alzheimer’s disease, which justifies the search for new effective therapies. The development of nanotechnology opens up new possibilities for the treatment of neuroinflammation. Gold and silver nanoparticles are gaining popularity, and the number of clinical trials involving metallic nanoparticles is constantly increasing. This paper reviews the research on gold and silver nanoparticles and their potential use in the treatment of herpesvirus neuroinfection. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Figure 1

21 pages, 1209 KiB  
Review
Role of Epitranscriptomic and Epigenetic Modifications during the Lytic and Latent Phases of Herpesvirus Infections
by Abel A. Soto, Gerardo Ortiz, Sofía Contreras, Ricardo Soto-Rifo and Pablo A. González
Microorganisms 2022, 10(9), 1754; https://doi.org/10.3390/microorganisms10091754 - 30 Aug 2022
Cited by 4 | Viewed by 2496
Abstract
Herpesviruses are double-stranded DNA viruses occurring at a high prevalence in the human population and are responsible for a wide array of clinical manifestations and diseases, from mild to severe. These viruses are classified in three subfamilies (Alpha-, Beta- and Gammaherpesvirinae [...] Read more.
Herpesviruses are double-stranded DNA viruses occurring at a high prevalence in the human population and are responsible for a wide array of clinical manifestations and diseases, from mild to severe. These viruses are classified in three subfamilies (Alpha-, Beta- and Gammaherpesvirinae), with eight members currently known to infect humans. Importantly, all herpesviruses can establish lifelong latent infections with symptomatic or asymptomatic lytic reactivations. Accumulating evidence suggest that chemical modifications of viral RNA and DNA during the lytic and latent phases of the infections caused by these viruses, are likely to play relevant roles in key aspects of the life cycle of these viruses by modulating and regulating their replication, establishment of latency and evasion of the host antiviral response. Here, we review and discuss current evidence regarding epitranscriptomic and epigenetic modifications of herpesviruses and how these can influence their life cycles. While epitranscriptomic modifications such as m6A are the most studied to date and relate to positive effects over the replication of herpesviruses, epigenetic modifications of the viral genome are generally associated with defense mechanisms of the host cells to suppress viral gene transcription. However, herpesviruses can modulate these modifications to their own benefit to persist in the host, undergo latency and sporadically reactivate. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Figure 1

14 pages, 1591 KiB  
Review
Replication Compartments—The Great Survival Strategy for Epstein–Barr Virus Lytic Replication
by Atsuko Sugimoto
Microorganisms 2022, 10(5), 896; https://doi.org/10.3390/microorganisms10050896 - 25 Apr 2022
Cited by 3 | Viewed by 2875
Abstract
During Epstein–Barr virus (EBV) lytic replication, viral DNA synthesis is carried out in viral replication factories called replication compartments (RCs), which are located at discrete sites in the nucleus. Viral proteins constituting the viral replication machinery are accumulated in the RCs to amplify [...] Read more.
During Epstein–Barr virus (EBV) lytic replication, viral DNA synthesis is carried out in viral replication factories called replication compartments (RCs), which are located at discrete sites in the nucleus. Viral proteins constituting the viral replication machinery are accumulated in the RCs to amplify viral genomes. Newly synthesized viral DNA is stored in a subdomain of the RC termed the BMRF1-core, matured by host factors, and finally packed into assembled viral capsids. Late (L) genes are transcribed from DNA stored in the BMRF1-core through a process that is mainly dependent on the viral pre-initiation complex (vPIC). RC formation is a well-regulated system and strongly advantageous for EBV survival because of the following aspects: (1) RCs enable the spatial separation of newly synthesized viral DNA from the cellular chromosome for protection and maturation of viral DNA; (2) EBV-coded proteins and their interaction partners are recruited to RCs, which enhances the interactions among viral proteins, cellular proteins, and viral DNA; (3) the formation of RCs benefits continuous replication, leading to L gene transcription; and (4) DNA storage and maturation leads to efficient progeny viral production. Here, we review the state of knowledge of this important viral structure and discuss its roles in EBV survival. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Figure 1

8 pages, 4657 KiB  
Review
Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival
by Takayuki Murata
Microorganisms 2021, 9(4), 778; https://doi.org/10.3390/microorganisms9040778 - 8 Apr 2021
Cited by 9 | Viewed by 2644
Abstract
The immune system has evolved as a complex and efficient means of coping with extrinsic materials, such as pathogens and toxins, as well as intrinsic abnormalities, such as cancers. Although rapid and timely activation of the immune system is obviously important, regulated downregulation [...] Read more.
The immune system has evolved as a complex and efficient means of coping with extrinsic materials, such as pathogens and toxins, as well as intrinsic abnormalities, such as cancers. Although rapid and timely activation of the immune system is obviously important, regulated downregulation of the system is almost as significant as activation to prevent runaway immunity, such as allergies and hypercytokinemia. Therefore, the immune checkpoint programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) pathway is beneficial for the host. On the other hand, pathogens have evolved to evade host immunity by taking advantage of the PD-1/PD-L1 pathway. This review is focused on human herpesviruses, such as herpes simplex virus (HSV), cytomegalovirus (CMV), and Epstein–Barr virus (EBV), which cause various types of disorders, and their relationships with the PD-1/PD-L1 pathway. Understanding such relationships will be useful for developing preventative and therapeutic methods for disorders caused by herpesviruses. Full article
(This article belongs to the Special Issue Herpesviruses: Basic, Applicative, and Translational Studies)
Show Figures

Figure 1

Back to TopTop